New Herpes Zoster Subunit Vaccine Cost-Effective
The new two-dose, adjuvanted herpes zoster subunit vaccine, approved in 2017, is cost-effective when compared with the live attenuated vaccine or with no...
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news
More News: Herpes | Primary Care | Shingles (Herpes Zoster) Vaccine | Vaccines | Varicella-Zoster Virus Vaccine